MAraviroc In HIV/ HCV Coinfection and Liver fibrosis

Trial Profile

MAraviroc In HIV/ HCV Coinfection and Liver fibrosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2013

At a glance

  • Drugs Maraviroc (Primary) ; Atazanavir; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
  • Indications Hepatitis C; HIV infections
  • Focus Therapeutic Use
  • Acronyms MAICOL
  • Most Recent Events

    • 26 Apr 2013 Interim results (n=57) after 48 weeks presented at the 48th Annual Meeting of the European Association for the Study of the Liver.
    • 09 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top